Acutus Medical Board Appoints John Sheridan as a New Director
18 March 2021 - 9:00PM
Acutus Medical (Nasdaq: AFIB) today announced the appointment of
John Sheridan to the Company's Board of Directors effective March
17, 2021.
Since March 2019, Mr. Sheridan has been the
President and Chief Executive Officer of Tandem Diabetes Care,
Inc., a medical device company specializing in the design,
development and commercialization of products for people with
insulin-dependent diabetes. He has been a member of Tandem’s Board
of Directors since June 2019 and a member of the executive
management team since 2013.
"John has an accomplished track record of
growing medical device companies while consistently creating value
for all stakeholders, including patients, providers, and
shareholders," said Vince Burgess, President and CEO of Acutus
Medical. "This expertise, coupled with his leadership of successful
medical technology organizations, makes John a great addition to
our Board of Directors."
"I look forward to working alongside my fellow
Board members and company management to advance Acutus Medical’s
mission to provide patient-focused solutions for the
electrophysiology community," stated Mr. Sheridan. "I have spent my
career bringing groundbreaking technologies to people in need of
better therapeutic options and am excited to join Acutus’ Board at
a time of significant growth."
Prior to joining Tandem Diabetes Care, Mr.
Sheridan served as Chief Operating Officer of Rapiscan Systems,
Inc., a provider of security equipment and systems, from March 2012
to February 2013. Mr. Sheridan served as Executive Vice President
of Research and Development and Operations for Volcano Corporation,
a medical technology company, from November 2004 to March 2010.
From May 2002 to May 2004, Mr. Sheridan served as Executive Vice
President of Operations at CardioNet, Inc., a medical technology
company. From March 1998 to May 2002, he served as Vice President
of Operations at Digirad Corporation, a medical imaging company.
Mr. Sheridan holds a B.S. in Chemistry from the University of West
Florida and an M.B.A. from Boston University.
About Acutus MedicalAcutus Medical is an
arrhythmia management company focused on improving the way cardiac
arrhythmias are diagnosed and treated. Acutus is committed to
advancing the field of electrophysiology with a unique array of
products and technologies which will enable more physicians to
treat more patients more efficiently and effectively. Through
internal product development, acquisitions, and global
partnerships, Acutus has established a global sales presence
delivering a broad portfolio of highly differentiated
electrophysiology products that provide its customers with a
complete solution for catheter-based treatment of cardiac
arrhythmias in each of its geographic markets. Founded in 2011,
Acutus is based in Carlsbad, California.
Follow Acutus Medical on:
- Twitter: @AcutusMedical
- LinkedIn: www.linkedin.com/company/acutus-medical-inc-/
- Facebook: @AcutusMedical
Investor Contact:Caroline
CornerWestwicke ICRD:
415-314-1725Caroline.corner@westwicke.com
Holly WindlerM:
619-929-1275media@acutusmedical.com
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Apr 2024 to May 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From May 2023 to May 2024